English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

The purpose of this study was to evaluate accuracy of cord blood interleukin-6 (IL-6) as an early marker of early onset neonatal sepsis (EOS) in neonates with maternal risk factors.. Objectives: To evaluate accuracy of cord blood IL-6 as a predictor of early onset neonatal sepsis (EONS) in neonates with prenatal risk factors for sepsis. Patients and methods: The study included 80 neonates divided into two groups. Group(I) included 25 full-term and 25 preterm neonates. Group (II) included thirty healthy age and sex matched controls with mean gestational age 35.2±3.8. All patients were subjected to adequate history taking, full clinical examination, complete blood count, blood culture, cord blood interleukin-6 and serum high sensitive CRP for elevated IL-6 level. Results:IL-6 level was significantly higher in the group (I) compared with group(II). No significant correlation between gestational age and level of IL-6. The best cutoff value for serum interleukin-6 as a marker for early detection of neonatal sepsis is ≥50 pg/ml with sensitivity 96 % and specificity 100%. Conclusion: Cord blood IL-6 can be a sensitive predictor of early onset sepsis for neonates with high risk of sepsis.

Cord Blood Interleukin-6 as a Predictor of Early Onset Sepsis in High Risk Neonates